Most “best longevity supplements” lists rank by hype. An ingredient makes a few rounds on social media, lands in a handful of animal studies, and suddenly it’s everywhere. This guide works differently: the supplements below are ranked by the strength of human evidence behind them, not by how often they trend.
Some have decades of clinical trials. Others have promising human data but need more replication. A few are earlier-stage compounds worth knowing about. Understanding which is which is the difference between a supplement routine built on evidence and one built on optimism.
Key Takeaways
The Short Version
The longevity supplements with the strongest human evidence include NMN, omega-3s, urolithin A, CoQ10, creatine, and magnesium.
Most supplement lists don’t distinguish between human RCT data and animal studies — that distinction matters enormously for setting realistic expectations.
Evidence strength should drive your supplement priorities, starting with ingredients that have replicated human trial results before adding emerging compounds.
Quality matters as much as ingredient selection: third-party testing, transparent labeling, and standardized extracts separate effective formulas from label decoration.
How to Evaluate a Longevity Supplement
Before ranking specific ingredients, it helps to establish what “evidence” actually means in this context.
The strongest evidence comes from randomized controlled trials in humans — ideally double-blind, placebo-controlled, and replicated across multiple research groups. Below that sit systematic reviews of multiple studies, human observational data, and mechanistic research in humans. Animal and cell-based studies can point researchers toward promising pathways, but they don’t tell us how an ingredient will perform in a living human body.
Throughout this article, each ingredient is labeled with its current evidence tier:
| Tier | What It Means |
|---|---|
| Strong | Multiple human RCTs or large meta-analyses |
| Moderate | Promising human trials with solid mechanistic support |
| Emerging | Early human data or strong animal/mechanistic evidence |
This framing isn’t pessimistic — it’s how evidence-informed supplement decisions get made.
NMN (NAD+ Precursor): Cellular Energy Support With Human Trial Data
Evidence tier: Moderate
NAD+ is a coenzyme that every cell in the body needs for energy production, DNA repair, and sirtuin signaling — a set of proteins linked to cellular stress response and longevity pathways. The problem is that NAD+ levels decline measurably with age, and that decline appears to affect mitochondrial function across multiple organ systems.
NMN (nicotinamide mononucleotide) is a direct precursor to NAD+. Taking it orally raises blood NAD+ concentrations, which is now well-established in human trials.
In a randomized, multicenter, double-blind, placebo-controlled trial published in GeroScience, 80 middle-aged healthy adults received 300, 600, or 900 mg of NMN daily for 60 days. Blood NAD+ concentrations increased significantly in all NMN groups compared to placebo at both day 30 and day 60. Walking distance during a six-minute walking test improved significantly in treated groups. Biological age, measured via the Aging.Ai 3.0 calculator, increased in the placebo group but remained stable in all NMN-treated groups.
The caveat: raising NAD+ levels is not the same as confirmed longevity benefit in humans. Longer-term trials are still underway. What the current evidence supports is that NMN safely elevates NAD+ and may improve physical performance and metabolic markers in middle-aged adults.
Common doses in human trials: 300–900 mg daily.
Omega-3 Fatty Acids: The Foundation Supplement
Evidence tier: Strong
Omega-3s — particularly EPA and DHA from marine sources — have more accumulated human evidence than almost any compound in the longevity space. Their effects on cardiovascular inflammation, membrane integrity, and cellular health are among the most replicated findings in nutritional science.
A comprehensive systematic review and meta-analysis published in the Journal of the American College of Cardiology, covering 884 randomized controlled trials and more than 883,000 participants, found that omega-3 (n-3 fatty acid) supplementation was associated with reduced cardiovascular mortality, reduced myocardial infarction risk, and reduced coronary heart disease events. The relative risk reductions were statistically significant and consistent across the dataset.
Cardiovascular disease is one of the leading drivers of shortened lifespan, so a supplement with this level of evidence for cardiovascular protection earns its place at the top of any longevity stack.
Omega-3s also support cellular membrane integrity, modulate inflammatory signaling, and have been studied for effects on cognitive aging. No other longevity supplement category combines this breadth of human evidence with this degree of safety data.
Common doses: 1–3 g of combined EPA and DHA daily, ideally from a third-party tested source with verified oxidation standards.
Urolithin A: The Mitochondria Recycler
Evidence tier: Moderate
Urolithin A is a postbiotic compound — produced when gut bacteria metabolize polyphenols from pomegranate and ellagic acid-containing foods. Its primary mechanism is activating mitophagy: the process by which cells identify and clear dysfunctional mitochondria, then replace them with healthier ones.
As mitochondria age, they accumulate damage. Without efficient mitophagy, that damage accumulates faster, contributing to reduced cellular energy output and broader aging effects. Urolithin A appears to help restore that recycling process.
A randomized, placebo-controlled trial in Cell Reports Medicine tested urolithin A in middle-aged adults over four months. Participants supplementing with urolithin A showed approximately 12% improvement in muscle strength, clinically meaningful improvements in aerobic endurance (peak VO2), and improved performance on the six-minute walk test. Plasma acylcarnitine levels — a marker of mitochondrial efficiency — decreased significantly with urolithin A, and levels of proteins linked to mitophagy and mitochondrial metabolism in skeletal muscle increased.
This is one of the more robust human datasets for an emerging longevity compound. The mechanism (mitophagy activation) aligns with aging biology in a way that makes further research genuinely interesting.
Urolithin A is a core ingredient in BioLongevity’s BioRecharge formula, which combines it with C60 fullerene, pomegranate extract, and alpha-lipoic acid for broader mitochondrial and antioxidant support.
CoQ10: Energy and Vascular Support
Evidence tier: Strong
Coenzyme Q10 is a lipid-soluble compound produced naturally in the body that plays a direct role in the mitochondrial electron transport chain — the process that generates ATP, the body’s primary energy currency. CoQ10 also acts as an antioxidant within mitochondrial membranes, protecting them from oxidative damage.
Endogenous CoQ10 production declines with age. Statin medications further deplete it. Both factors make supplementation increasingly relevant over time.
The large micronutrient meta-analysis published in JACC found that CoQ10 supplementation was associated with a statistically significant reduction in all-cause mortality events in the dataset. In a separate randomized clinical trial in Nutrients, elderly subjects supplementing with combined selenium and CoQ10 for 42 months showed significantly less telomere shortening compared to placebo, and that telomere preservation was associated with reduced cardiovascular mortality over a 10-year follow-up period.
Telomere attrition is one of the recognized hallmarks of biological aging. Evidence linking CoQ10 supplementation to reduced telomere shortening and lower cardiovascular mortality is worth taking seriously.
Creatine: Not Just for Athletes
Evidence tier: Strong
Creatine monohydrate is one of the most studied compounds in all of sports science, but its relevance to healthy aging goes well beyond gym performance. Creatine supports ATP regeneration in muscle and neural tissue, helping cells maintain energy output under physical and metabolic stress — the kind of stress that compounds with age.
A systematic review of 17 randomized controlled trials published in the Journal of Geriatric Physical Therapy found that creatine supplementation combined with exercise improved upper and lower body strength, functional capacity, and lean mass in older adults. Improvements were particularly consistent in older women. Safety data across all reviewed trials supported creatine monohydrate as well-tolerated in aging populations.
For anyone over 40, creatine is arguably the most evidence-backed supplement for maintaining muscle mass, functional strength, and cellular energy capacity simultaneously. It’s also inexpensive, widely available, and has decades of safety data.
Typical dose: 3–5 g daily. Loading phases are optional.
Magnesium: The Deficiency Most People Miss
Evidence tier: Strong
Magnesium is a cofactor for more than 300 enzymatic reactions in the body, including pathways involved in DNA synthesis, protein synthesis, energy metabolism, and nervous system function. Deficiency becomes more common with age, driven by reduced dietary intake, impaired absorption, and increased urinary excretion.
A review published in Nutrients documented the close relationship between magnesium deficit and hypertension in older adults — a major risk factor for cardiovascular mortality. Older populations are disproportionately affected by both magnesium deficiency and its downstream consequences. The authors found evidence across epidemiological, experimental, and clinical datasets supporting a protective effect of adequate magnesium on hypertension risk.
Hypertension accelerates biological aging through effects on vascular stiffness, kidney function, and cardiovascular risk. A supplement with strong evidence for supporting blood pressure already within normal range and cardiovascular health belongs in any foundational longevity routine.
Form matters: magnesium glycinate and magnesium L-threonate have better absorption and tolerability profiles than oxide forms.
Peptide Bioregulators: The Advanced Category
Evidence tier: Emerging to Moderate
Peptide bioregulators are short-chain peptides (typically di-, tri-, and tetrapeptides) derived from specific organ and tissue sources. Their proposed mechanism involves binding to chromatin in cell nuclei and influencing gene expression in tissue-specific ways — essentially acting as regulatory signals for cellular function in the tissue they were derived from.
The foundational research behind this category comes from decades of work at the St. Petersburg Institute of Bioregulation and Gerontology, led by researchers including Vladimir Khavinson. A review in Biogerontology summarized findings from long-term studies showing that peptide preparations increased mean lifespan by 20–40% in rodent models, slowed age-related biomarker changes, and, importantly, included clinical application data from 6–12 year human use periods.
The animal data is strong; human clinical trial data is more limited compared to the other categories in this list, which is why this sits as an emerging-to-moderate tier compound category.
Peptide bioregulators are tissue-specific — there are separate complexes for the brain, thymus, pineal gland, heart, liver, and other organ systems. This specificity is what makes them interesting as an advanced longevity category beyond general antioxidant support.
BioLongevity carries a full range of organ-specific peptide bioregulator capsules in our bioregulator collection for consumers who want to explore this category.
What to Look for in a Quality Longevity Supplement
Ingredient selection only gets you part of the way. A poorly manufactured or under-dosed formula won’t deliver results that match the research it references.
Before purchasing any longevity supplement, check for:
- Third-party testing — an independent lab verifying that what’s on the label is actually in the capsule at the stated dose
- Certificate of Analysis (COA) — the test documentation that proves purity, potency, and the absence of contaminants
- Transparent labeling — no proprietary blends that hide individual ingredient doses
- Standardized extracts — for botanical ingredients, standardization to active compound percentages (e.g., polyphenols, curcuminoids) ensures consistent potency
- Appropriate form — CoQ10 as ubiquinol, magnesium as glycinate or L-threonate, NMN verified for purity above 98%
A supplement that contains the right ingredient at an unstandardized dose in an untested formula is not equivalent to the compound studied in clinical trials.
Frequently Asked Questions
What makes a longevity supplement different from a regular supplement?
Longevity supplements target the biological mechanisms associated with aging — mitochondrial function, cellular energy, oxidative stress, NAD+ metabolism, and inflammatory signaling — rather than addressing an acute deficiency. They’re designed for long-term use as part of a healthy aging routine, not short-term symptom relief.
Do longevity supplements actually extend lifespan?
No human supplement has been proven to extend lifespan in the way that caloric restriction or certain genetic factors have been studied. What the current human evidence supports is that some compounds — particularly omega-3s, CoQ10, NMN, and urolithin A — may support healthspan: the portion of life spent in good functional health. These are different but related concepts.
How long before longevity supplements produce noticeable results?
Compounds that support mitochondrial health, NAD+ levels, or cardiovascular function typically show measurable changes in biomarkers within 4–12 weeks of consistent use. Functional improvements (energy, physical performance, muscle strength) may be noticeable sooner. The longevity benefits of consistent supplementation are cumulative over years, not days.
Can I take all of these supplements together?
Most combinations are compatible. Omega-3s, magnesium, creatine, CoQ10, urolithin A, and NMN can generally be used concurrently. As with any supplement protocol — especially if you take prescription medications or manage a medical condition — confirm the combination with a qualified healthcare provider before starting.
Which longevity supplement should I start with?
If you’re new to this category, the evidence supports starting with the foundational tier: omega-3s, magnesium, CoQ10, and creatine. These have the broadest human evidence and apply to the most people. NMN and urolithin A are logical next additions for those who want to build on that base. Peptide bioregulators represent a more advanced and specialized category.
Ask a qualified clinician before starting any supplement if you are pregnant, nursing, taking medication, or managing a medical condition.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
References
[1] Singh A, D’Amico D, Andreux PA, et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Rep Med. 2022;3(5):100633. doi:10.1016/j.xcrm.2022.100633
[2] Yi L, Maier AB, Tao R, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45(1):29–43. doi:10.1007/s11357-022-00705-1
[3] An P, Wan S, Luo Y, et al. Micronutrient Supplementation to Reduce Cardiovascular Risk. J Am Coll Cardiol. 2022;80(24):2269–2285. doi:10.1016/j.jacc.2022.09.048
[4] Opstad TB, Alexander J, Aaseth JO, et al. Selenium and Coenzyme Q10 Intervention Prevents Telomere Attrition, with Association to Reduced Cardiovascular Mortality — Sub-Study of a Randomized Clinical Trial. Nutrients. 2022;14(16):3346. doi:10.3390/nu14163346
[5] Stares A, Bains M. The Additive Effects of Creatine Supplementation and Exercise Training in an Aging Population: A Systematic Review of Randomized Controlled Trials. J Geriatr Phys Ther. 2020;43(2):99–112. doi:10.1519/JPT.0000000000000222
[6] Dominguez L, Veronese N, Barbagallo M. Magnesium and Hypertension in Old Age. Nutrients. 2021;13(1):139. doi:10.3390/nu13010139
[7] Anisimov VN, Khavinson VKh. Peptide bioregulation of aging: results and prospects. Biogerontology. 2010;11(2):139–149. doi:10.1007/s10522-009-9249-8